Kelly C et al. |
Macrolide antibiotics for bronchiectasis. |
2018 |
Cochrane Database Syst Rev |
pmid:29543980
|
Yeo YH et al. |
First-line eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. |
2018 |
Gut |
pmid:27670375
|
Suzuki R et al. |
Sinobronchial syndrome treated as intractable asthma. |
2018 |
Pediatr Int |
pmid:30320426
|
Mégraud F |
Antibiotic Resistance Is the Key Element in Treatment of Helicobacter pylori Infection. |
2018 |
Gastroenterology |
pmid:30308190
|
Mieras LF et al. |
An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+. |
2018 |
BMC Infect. Dis. |
pmid:30290790
|
Liou JM et al. |
Toward population specific and personalized treatment of Helicobacter pylori infection. |
2018 |
J. Biomed. Sci. |
pmid:30285834
|
Liu HY et al. |
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction. |
2018 |
J Refract Surg |
pmid:30199569
|
Kabakambira JD et al. |
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial. |
2018 |
BMC Gastroenterol |
pmid:30165823
|
Yotsu RR et al. |
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). |
2018 |
Cochrane Database Syst Rev |
pmid:30136733
|
Abu-Khalaf N et al. |
The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation. |
2018 |
Sensors (Basel) |
pmid:29401675
|
Tanabe H et al. |
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29950163
|
Sandri A et al. |
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice. |
2018 |
Virulence |
pmid:29938577
|
Gonzalez-Hormazabal P et al. |
Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa. |
2018 |
BMC Gastroenterol |
pmid:29925321
|
|
Clarithromycin in patients with coronary artery disease. |
2018 |
Med Lett Drugs Ther |
pmid:29913468
|
Li M et al. |
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori. |
2018 |
Helicobacter |
pmid:29873436
|
Blümel B et al. |
Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing. |
2018 |
Helicobacter |
pmid:29873430
|
Ito M et al. |
Phase transitions of antibiotic clarithromycin forms I, IV and new form VII crystals. |
2018 |
Int J Pharm |
pmid:29864514
|
Jin BH et al. |
Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29846770
|
Auesomwang C et al. |
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication. |
2018 |
J. Gastroenterol. Hepatol. |
pmid:29804294
|
Chai KY et al. |
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report. |
2018 |
J Med Case Rep |
pmid:29743095
|
Strouvalis I et al. |
Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence. |
2018 |
Respirology |
pmid:29741298
|
Long X et al. |
Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance. |
2018 |
Helicobacter |
pmid:29696736
|
Fiorini G et al. |
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016. |
2018 |
Scand. J. Gastroenterol. |
pmid:29688095
|
Matta AJ et al. |
Punctual mutations in gene of clarithromycin-resistant in Colombian populations. |
2018 |
World J. Gastroenterol. |
pmid:29662291
|
Takemori N et al. |
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report. |
2018 |
J Med Case Rep |
pmid:29454372
|
Xu R et al. |
Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29453492
|
Tsutsui A et al. |
Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. |
2018 |
J. Infect. Chemother. |
pmid:29428566
|
Tarhini M et al. |
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy. |
2018 |
Microb. Pathog. |
pmid:29428426
|
Kobayashi T et al. |
The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma. |
2018 |
Ann. Hematol. |
pmid:29427183
|
Wang S et al. |
Enhanced adsorption of ionizable antibiotics on activated carbon fiber under electrochemical assistance in continuous-flow modes. |
2018 |
Water Res. |
pmid:29426033
|
Yagbasan A et al. |
A Prospective, randomized study comparing 7-day and 14-day quadruple therapies as first-line treatments for helicobacter pylori infection in patients with functional dyspepsia. |
2018 |
Niger J Clin Pract |
pmid:29411724
|
Maiolino G et al. |
Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism. |
2018 |
Blood Press. |
pmid:29409357
|
Takahashi E et al. |
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus. |
2018 |
Comp. Immunol. Microbiol. Infect. Dis. |
pmid:29406285
|
Wang YH et al. |
A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori. |
2018 |
Helicobacter |
pmid:29405526
|
Tso S et al. |
Clarithromycin as a steroid sparing agent for the management of infantile bullous pemphigoid. |
2018 |
BMJ Case Rep |
pmid:29374651
|
Sahara S et al. |
Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. |
2018 |
Digestion |
pmid:29310119
|
Aderemi AO et al. |
Oxidative stress responses and cellular energy allocation changes in microalgae following exposure to widely used human antibiotics. |
2018 |
Aquat. Toxicol. |
pmid:30125766
|
Sue S et al. |
Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial. |
2018 |
Helicobacter |
pmid:29271026
|
Iwamoto J et al. |
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. |
2018 |
Intern. Med. |
pmid:29093413
|
Ersoy B et al. |
The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs. |
2018 |
J Laryngol Otol |
pmid:29888693
|
Inagaki Y et al. |
Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome. |
2018 |
Intern. Med. |
pmid:29093379
|
De Francesco V et al. |
Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study. |
2018 |
Dig Liver Dis |
pmid:29089267
|
Cerqueira RM et al. |
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery. |
2018 |
Obes Surg |
pmid:29076008
|
Haj Yahia S et al. |
Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. |
2018 |
Rheumatol. Int. |
pmid:28975396
|
Shaharir SS et al. |
Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis. |
2018 |
Clin. Rheumatol. |
pmid:28971307
|
Marsousi N et al. |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software. |
2018 |
Biopharm Drug Dispos |
pmid:28960401
|
Popovic V et al. |
Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome. |
2018 |
Folia Microbiol. (Praha) |
pmid:28913757
|
Hosono Y et al. |
The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. |
2018 |
J. Infect. Chemother. |
pmid:29361415
|
Sancak S et al. |
A pioneering study: oral clarithromycin treatment for feeding intolerance in very low birth weight preterm infants. |
2018 |
J. Matern. Fetal. Neonatal. Med. |
pmid:28279123
|
Alenezi A et al. |
Controlled release of clarithromycin from PLGA microspheres enhances bone regeneration in rabbit calvaria defects. |
2018 |
J. Biomed. Mater. Res. Part B Appl. Biomater. |
pmid:28067984
|